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An investigation of NFXL1, a gene




Background: A recent study identified NFXL1 as a candidate gene for specific language impairment. The protein
encoded by this gene is predicted to be a transcription factor based on domain similarities with NFX1, a repressor
of HLA class II genes, which have themselves been implicated in specific language impairment. However, there is
very little literature on the function of NFXL1.
Methods: This report describes a study of NFXL1 expression in several human tissues and an investigation of
differential expression in several specific brain regions through quantitative PCR as well as a study of the protein’s
sub-cellular localization in HEK cells and SH-SY5Y cells through immunofluorescence.
Results: The NFXL1 transcript was found in all investigated tissues. In the brain, a high level of NFXL1 expression
was found in the cerebellum. An analysis of the sub-cellular localization of the protein showed a cytoplasmic
pattern in the investigated cells.
Conclusions: The NFXL1 transcript was present in samples from different tissues; in the brain, a high expression
level was found in a region implicated in some language-related pathologies. NFXL1 did not show nuclear
localization, suggesting that, if it regulates transcription, certain conditions may be required for it to translocate to
the nucleus.
Keywords: Specific language impairment, NFXL1, Neurogenetics, Neurodevelopment, Language disorder,
Transcription factor, Cerebellum
Background
Specific language impairment (SLI) is diagnosed when a
child has problems with language acquisition in the
context of otherwise typical cognitive development [1].
Recently, an exome-sequencing study of SLI identified a
new candidate gene, NFXL1 [2]. The protein is predicted
to be a transcription factor based on domain similarities
with NFX1 (a transcription factor which represses HLA
class II genes [3]), which include RING-type and NF-X1-
type zinc finger predicted domains. Interestingly, some
alleles of HLA class II genes were highlighted in a study
of SLI and HLA alleles [4]. To date, NFXL1 has received
little attention, but a study that examined a cloned frag-
ment of the gene in HeLa cells found that it localized in
the cytoplasm [5]. The aim of this study was to investi-
gate NFXL1 at both the transcript and the protein levels.
Methods
To detect the NFXL1 transcript in various tissues, Amsbio
cDNA human adult normal tissue major panels 1 and 2
(heart, brain, kidney, liver, lung, pancreas, spleen, skeletal
muscle, and placenta) were used. RNA obtained from
Clontech was used to examine differential expression in
the brain. The samples consisted of RNA pooled from the
brains of several adult donors (numbers vary by sample):
whole brain, temporal lobe, frontal lobe, parietal lobe,
cerebral cortex, and cerebellum. The QuantiTect Reverse
Transcription kit (Qiagen) was used with 0.5 μg RNA to
produce cDNA for use in a quantitative PCR (qPCR).
cDNA for the brain regions was diluted 1:10 for use in
qPCR on a Bio-Rad iQ5 machine. cDNA from the tissue
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panels was not diluted. The following TaqMan assays (Life
Technologies) were used: Hs00541755_m1 (NFXL1) and
Hs99999905_m1 (GAPDH, used as a housekeeping gene)
with the standard TaqMan protocol. RNA-negative con-
trols and reverse-transcriptase-negative controls were
used. cDNA samples originating from RNA-positive sam-
ples were run as three replicates, and cycle-threshold
values were averaged across all replicates for downstream
analyses. Relative expression levels were estimated using
the ΔΔCT method [6] with samples normalized to the
whole brain.
Immunofluorescence (IF) and western blot (WB) experi-
ments were performed with HEK-293T cells grown in
Dulbecco’s Modified Eagle’s Medium (Sigma) supple-
mented with 2 mM L-glutamine, 10 % fetal bovine serum,
and 1 % penicillin/streptomycin. HEK cells naturally
expressed NFXL1 (detected using the TaqMan assay), and
the presence of the endogenous protein was confirmed
through western blotting. IF experiments were also per-
formed with a neuronal cell line, SH-SY5Y. SH-SY5Y cells
were grown in a medium consisting of 1:1 Minimum Es-
sential Medium Eagle (Sigma) and Nutrient Mixture F-12
Ham (Sigma). The medium was supplemented with 2 mM
L-glutamine, 1 % non-essential amino acids, 15 % fetal bo-
vine serum, and 1 % penicillin/streptomycin. The cells were
grown at 37 °C and 5 % CO2. The medium was changed
every 1–3 days, and when the cells were at least 80 % con-
fluent, the cell culture was split using trypsin/EDTA.
HEK cell RNA was extracted with RNeasy Mini kit
(Qiagen). The presence in HEK cells of the transcripts of
the HLA class II genes included in the study of HLA
and SLI was assessed with TaqMan assays: HLA-DRB1
(Hs04192464_mH), HLA-DQA1 (Hs03007426_mH), and
HLA-DQB1 (Hs03054971_m1). Cells were transfected
with a plasmid containing the NFXL1 cDNA and a Myc-
DDK tag (RC216989, Origene) with 0.75 μg plasmid and
1 μl jetPRIME (Polyplus transfections) for IF for HEK
cells (0.5 μg plasmid for SH-SY5Y cells) (24-well plate,
using coverslips coated with poly-L-lysine) and 3 μg
plasmid and 4 μl jetPRIME for WB (6-well plate). Con-
trol cells for WB were transfected with the empty vector
(pCMV6-Entry Vector, Origene), while control cells for
IF were not transfected. Cells were analyzed 24 h after
the transfection medium had been changed (4 h after
transfection). For IF, cells were fixed with cold methanol
for 10 min and subjected to treatment with a blocking
and permeabilization solution (0.1 % Triton X-100,
10 mg/ml (1 %) fish gelatin, 10 % normal goat serum in
TBS). The primary antibodies were rabbit anti-NFXL1
A303-197A (Bethyl) and mouse anti-DDK TA50011-100
(Origene). The secondary antibodies were Alexa Fluor-
conjugated antibodies anti-rabbit (594, red) and anti-
mouse (488, green). The dilution factor for all antibodies
was 1:500. Cells were also stained with DAPI (4',6-
diamidino-2-phenylindole). The cells were stained for
1 h and washed with PBS five times after each staining
for 10 min (three washes after DAPI staining). A Zeiss
LSM 510 Meta Confocal Microscope was used in the
IF experiments. For WB, cells were lysed on ice for
30 min using 50 mM Tris-HCl pH 7.8, 150 mM NaCl,
1 mM EDTA, 1 % Triton X-100, and 1× protease in-
hibitor cocktail (Roche). Protein concentration was
measured with Pierce BCA Assay (Thermo Fisher). Elec-
trophoresis and transfer were performed using the
NuPAGE system (Invitrogen) following the manufacturer
protocol for 7 % Tris-Acetate mini gels. The samples were
heated at 70 °C for 10 min prior to being loaded onto the
gel. Following the transfer, the PVDF membrane was
blocked in 5 % skimmed milk dissolved in TBS Tween-20
0.1 % for at least 30 min. Blotting was performed with
anti-NFXL1 A303-197A 1:2000 (in 1 % skimmed milk in
TBS Tween-20) overnight at 4 °C. The secondary antibody
was goat anti-rabbit IgG (H+L)-HRP conjugate (Bio-Rad)
1:5000 (1-h blotting at room temperature). After each
blotting, the membrane was washed with TBS Tween-20
three times (10 min each). Amersham Biosciences ECL
Plus kit was used. Pictures were taken with a Bio-Rad
ChemiDoc MP imaging system.
Results
The NFXL1 transcript was detected (i.e., CT values were
obtained) in the heart, brain, kidney, liver, lung, pan-
creas, spleen, skeletal muscle, and placenta. A quantita-
tive expression analysis across different tissues through
PCR is problematic due to the fact that expression levels
of housekeeping genes may differ across tissues, but the
fact that CT values were obtained for all tissues indicates
that the transcript was present in all samples. A qPCR
with cDNA from several brain regions associated with
language was performed to assess the expression levels
of NFXL1 in those regions. As shown in Table 1, the
cerebellum had the highest expression level. Addition-
ally, a regular PCR and a gel electrophoresis were per-
formed to confirm the presence of the transcript in
samples from the various brain regions, and it was
found in all of them (Additional file 1).
WB analysis showed that the tagged protein was highly
expressed and that it was slightly bigger than the en-
dogenous protein (Fig. 1a). CT values were obtained for
all HLA class II genes studied using qPCR for HEK cell
cDNA (HLA-DRB1, HLA-DQA1, and HLA-DQB1), sug-
gesting that HEK cells naturally expressed putative
NFXL1 targets. Two out of those three HLA class II
genes (HLA-DRB1 and HLA-DQA1) showed association
with SLI [4]. HEK cells were therefore used to examine
the cellular localization of the protein through IF. In
HEK cells transfected with the NFXL1 plasmid, the over-
expressed protein was observed in the cytoplasm, where
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it could be detected with both the antibody for the en-
dogenous protein and the antibody for the tag (Fig. 1b–d).
Endogenous NFXL1 was not detected in control cells
using the antibody for the endogenous protein in the IF
experiments, possibly due to low levels of the endogenous
protein compared to the background signal, although it
was detected through WB (Fig. 1a). The IF experiment
was performed again, with SH-SY5Y cells. No signal dis-
tinguishable from the background was detected with the
antibody for the tag. However, a strong signal from the
antibody for the endogenous protein was obtained for
some cells in both the transfected and the control cul-
tures. In those cases, the signal was not nuclear and ap-
peared cytoplasmic, as in the case of the overexpressed
protein in HEK cells (Fig. 2a–d).
Discussion
Recently, mutations in NFXL1 have been implicated in
SLI [2]. The present study shows that NFXL1 is
expressed in many different types of tissues. While test-
ing for relative expression levels across different tissues
through qPCR is problematic due to differences in the
Table 1 Expression analysis results. Mean CT values from qPCR for examined brain regions for NFXL1 and GAPDH, standard












GAPDH mean CT 24.06 21.84 21.93 21.63 21.96 22.14
GAPDH standard deviation 0.048 0.106 0.064 0.055 0.132 0.005
NFXL1 mean CT 32.21 30.69 28.25 28.35 28.47 27.91
NFXL1 standard deviation 0.267 0.04 0.213 0.157 0.193 0.244
NFXL1 expression level in brain regions relative to the whole
brain
1 0.62 3.56 2.69 3.12 5.21
Fig. 1 Western blot and immunofluorescence results for HEK cells. a Western blot image showing the overexpression of tagged NFXL1 in cells
transfected with the NFXL1 plasmid compared to control cells. Samples of two micrograms of protein lysate were loaded onto the gel. Exposure time
was 20 s. The protein ladder is superimposed with the WB image. The endogenous NFXL1 is expected to have a mass of 101 kDa. b
Immunofluorescence of successfully transfected HEK cells showing overexpressed NFXL1 with the antibody for the endogenous protein. c
Immunofluorescence of successfully transfected HEK cells showing overexpressed NFXL1 with the antibody for the DDK tag. d Superimposed images
showing signals from both antibodies and a DAPI staining of the cell nuclei
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expression levels of housekeeping genes across different
tissues, GAPDH has been shown to have little variation
in tissues belonging to the nervous system [7]. The re-
sults show that the NFXL1 expression level in the cere-
bellum is more than five times higher than that in the
whole brain. While the cerebellum is mostly thought of
in the context of motor function, some studies have im-
plicated it in language disorders: Silveri et al. reported
on a patient with a right cerebellar infarction who devel-
oped problems with the morphological component of
language [8]. Fabbro et al. reported on four patients with
cerebellar lesions who had problems with morphology
and syntax [9]. The high expression level in the cerebel-
lum is in line with the high expression of NFXL1 re-
ported for the cerebellar cortex in the Allen Brain Atlas
[10], with a maximum Z-score of 2.12945. Similarly, the
highest reads per kilobase of transcript per million
mapped reads (RPKM) values for NFXL1 across all brain
tissues as reported in the GTEx database [11] were those
obtained for the cerebellar hemisphere and the cerebel-
lum (median RPKM values of 3.916 and 3.906,
respectively).
The IF experiments showed a strong cytoplasmic sig-
nal from the overexpressed NFXL1 protein in HEK cells
and the endogenous protein in SH-SY5Y cells. In HEK
cells, the localization could be checked with the antibody
for the tag as well as the antibody for the endogenous
protein at the same time (with antibodies from two dif-
ferent species). The results show that both antibodies
provided the same signal (red and green in Fig. 1b, c, re-
spectively), suggesting that both antibodies detected the
same protein. It is possible that the tag influenced the
localization of the protein. However, tagged proteins are
routinely used in ChIP-Seq experiments to study nuclear
proteins [12], and, in the case of the SH-SY5Y cells, some
of the control cells showed cytoplasmic localization of en-
dogenous NFXL1, i.e., when a signal was detected, it was
cytoplasmic (Fig. 2c). These results are in line with a pre-
vious study, in which a small part of the NFXL1 gene was
cloned into a vector with a green fluorescent protein tag
and transfected into HeLa cells. The resulting fusion pro-
tein localized in the cytoplasm [5]. In UniProt [13], the
protein is annotated as nuclear and membranal, based on
different predictions.
Conclusions
This investigation is of a descriptive nature and was de-
signed as a primary study of NFXL1. It provides experi-
mental evidence that highlighted its high expression in a
brain region that is relevant to language and experimen-
tally confirmed its presence in a variety of tissues. The
protein was not observed in the cell nucleus in exam-
ined cell lines, suggesting that, if it functions as a tran-
scription factor, it may translocate to the nucleus under
conditions not present in this study. Further functional
studies are required in order to elucidate the involve-
ment of NFXL1 in SLI. The development of high-grade
antibodies for NFXL1 and large-scale analyses of mul-
tiple cell lines in which NFXL1 might show nuclear
localization would allow us to achieve a better under-
standing of its function and potential role in neural
development.
Availability of data and materials
The materials described in this study are available com-
mercially. Reagents, kits, and RNA/cDNA samples were
obtained from the companies mentioned in the main
text.
Additional file
Additional file 1: Amplification of a fragment of NFXL1 cDNA in
examined brain regions. Gel electrophoresis picture showing a fragment of
NFXL1 cDNA amplified by regular PCR, and the PCR protocol. (PDF 46.2 kb)
Fig. 2 Immunofluorescence results for SH-SY5Y cells. a A representative cell from the transfected cell culture showing NFXL1 with the antibody
for the endogenous protein. b A representative cell from the transfected cell culture showing NFXL1 with the antibody for the endogenous pro-
tein superimposed with the DAPI staining of the cell nuclei. c A representative cell from the control cell culture showing endogenous NFXL1 with
the antibody for the endogenous protein. d A representative cell from the control cell culture showing endogenous NFXL1 with the antibody for
the endogenous protein superimposed with the DAPI staining of the cell nuclei
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